HEADER ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)11-APR-91 4TIM TITLE CRYSTALLOGRAPHIC AND MOLECULAR MODELING STUDIES ON TRYPANOSOMAL TITLE 2 TRIOSEPHOSPHATE ISOMERASE: A CRITICAL ASSESSMENT OF THE PREDICTED AND TITLE 3 OBSERVED STRUCTURES OF THE COMPLEX WITH 2-PHOSPHOGLYCERATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 5.3.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 3 ORGANISM_TAXID: 5702; SOURCE 4 STRAIN: BRUCEI KEYWDS ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE) EXPDTA X-RAY DIFFRACTION AUTHOR M.E.M.NOBEL,R.K.WIERENGA,W.G.J.HOL REVDAT 4 28-FEB-24 4TIM 1 REMARK REVDAT 3 24-FEB-09 4TIM 1 VERSN REVDAT 2 01-APR-03 4TIM 1 JRNL REVDAT 1 15-OCT-92 4TIM 0 JRNL AUTH M.E.NOBLE,C.L.VERLINDE,H.GROENDIJK,K.H.KALK,R.K.WIERENGA, JRNL AUTH 2 W.G.HOL JRNL TITL CRYSTALLOGRAPHIC AND MOLECULAR MODELING STUDIES ON JRNL TITL 2 TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE: A CRITICAL JRNL TITL 3 ASSESSMENT OF THE PREDICTED AND OBSERVED STRUCTURES OF THE JRNL TITL 4 COMPLEX WITH 2-PHOSPHOGLYCERATE. JRNL REF J.MED.CHEM. V. 34 2709 1991 JRNL REFN ISSN 0022-2623 JRNL PMID 1895291 JRNL DOI 10.1021/JM00113A007 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.E.M.NOBLE,R.K.WIERENGA,A.-M.LAMBEIR,F.R.OPPERDOES, REMARK 1 AUTH 2 A.-M.W.H.THUNNISSEN,K.H.KALK,H.GROENDIJK,W.G.J.HOL REMARK 1 TITL THE ADAPTABILITY OF THE ACTIVE SITE OF TRYPANOSOMAL REMARK 1 TITL 2 TRIOSEPHOSPHATE ISOMERASE AS OBSERVED IN THE CRYSTAL REMARK 1 TITL 3 STRUCTURES OF THREE DIFFERENT COMPLEXES REMARK 1 REF PROTEINS V. 10 50 1991 REMARK 1 REFN ISSN 0887-3585 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.K.WIERENGA,M.E.M.NOBLE,J.P.M.POSTMA,H.GROENDIJK,K.H.KALK, REMARK 1 AUTH 2 W.G.J.HOL,F.R.OPPERDOES REMARK 1 TITL THE CRYSTAL STRUCTURE OF THE "OPEN" AND THE "CLOSED" REMARK 1 TITL 2 CONFORMATION OF THE FLEXIBLE LOOP OF TRYPANOSOMAL REMARK 1 TITL 3 TRIOSEPHOSPHATE ISOMERASE REMARK 1 REF PROTEINS V. 10 33 1991 REMARK 1 REFN ISSN 0887-3585 REMARK 1 REFERENCE 3 REMARK 1 AUTH R.K.WIERENGA,M.E.M.NOBLE,G.VRIEND,S.NAUCHE,W.G.J.HOL REMARK 1 TITL REFINED 1.83 ANGSTROMS STRUCTURE OF TRYPANOSOMAL REMARK 1 TITL 2 TRIOSEPHOSPHATE ISOMERASE, CRYSTALLIZED IN THE PRESENCE OF REMARK 1 TITL 3 2.4 M-AMMONIUM SULPHATE. A COMPARISON WITH THE STRUCTURE OF REMARK 1 TITL 4 THE TRYPANOSOMAL TRIOSEPHOSPHATE REMARK 1 TITL 5 ISOMERASE-GLYCEROL-3-PHOSPHATE COMPLEX REMARK 1 REF J.MOL.BIOL. V. 220 995 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.K.WIERENGA,K.H.KALK,W.G.J.HOL REMARK 1 TITL STRUCTURE DETERMINATION OF THE GLYCOSOMAL TRIOSEPHOSPHATE REMARK 1 TITL 2 ISOMERASE FROM TRYPANOSOMA BRUCEI BRUCEI AT 2.4 ANGSTROMS REMARK 1 TITL 3 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 198 109 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.K.WIERENGA,W.G.J.HOL,O.MISSET,F.R.OPPERDOES REMARK 1 TITL PRELIMINARY CRYSTALLOGRAPHIC STUDIES OF TRIOSEPHOSPHATE REMARK 1 TITL 2 ISOMERASE FROM THE BLOOD PARASITE TRYPANOSOMA BRUCEI BRUCEI REMARK 1 REF J.MOL.BIOL. V. 178 487 1984 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17456 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3766 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 11 REMARK 3 SOLVENT ATOMS : 130 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.013 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TIM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE CRYSTALS USED FOR THIS STRUCTURE REMARK 280 DETERMINATION WERE GROWN IN THE PRESENCE OF 2.4M AMMONIUM REMARK 280 SULFATE (SEE PROTEIN DATA BANK ENTRIES 2TIM AND 5TIM), BUT REMARK 280 BEFORE DATA COLLECTION THESE CRYSTALS WERE TRANSFERRED TO A REMARK 280 MOTHER LIQUOR WITHOUT SULFATE CONTAINING 30MM 2- REMARK 280 PHOSPHOGLYCERATE. THE ACTIVE SITE OF CHAIN *A* ("OPEN"- REMARK 280 CONFORMATION) HAS NO BOUND 2-PHOSPHOGLYCERATE. THE ACTIVE SITE REMARK 280 OF CHAIN *B* ("CLOSED"-CONFORMATION) HAS A BOUND 2- REMARK 280 PHOSPHOGLYCERATE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.29500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.64500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 23.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.29500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.64500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONSISTS OF A DIMER. THE TWO MOLECULES REMARK 300 HAVE BEEN ASSIGNED CHAIN INDICATORS *A* AND *B*. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 SECONDARY STRUCTURE SPECIFICATIONS WERE MADE BY USE OF REMARK 400 PROGRAM *DSSP* OF W. KABSCH AND C. SANDER. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 205 NH2 ARG A 220 2564 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 53 CD GLU A 53 OE2 0.074 REMARK 500 GLU A 97 CD GLU A 97 OE2 0.069 REMARK 500 GLU A 104 CD GLU A 104 OE2 0.094 REMARK 500 GLU A 107 CD GLU A 107 OE2 0.066 REMARK 500 GLU A 129 CD GLU A 129 OE2 0.082 REMARK 500 GLU A 167 CD GLU A 167 OE2 0.086 REMARK 500 GLU A 205 CD GLU A 205 OE2 0.072 REMARK 500 GLU B 23 CD GLU B 23 OE2 0.067 REMARK 500 GLU B 53 CD GLU B 53 OE2 0.071 REMARK 500 GLU B 77 CD GLU B 77 OE2 0.083 REMARK 500 GLU B 104 CD GLU B 104 OE2 0.075 REMARK 500 GLU B 133 CD GLU B 133 OE2 0.071 REMARK 500 GLU B 185 CD GLU B 185 OE1 0.078 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 111 CB - CG - OD1 ANGL. DEV. = 6.8 DEGREES REMARK 500 ASP A 111 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ARG A 134 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 134 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 138 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP A 158 CB - CG - OD2 ANGL. DEV. = -7.6 DEGREES REMARK 500 ASP A 201 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP A 201 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ARG A 207 CD - NE - CZ ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG A 207 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP A 227 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES REMARK 500 ASP A 244 CB - CG - OD1 ANGL. DEV. = -7.5 DEGREES REMARK 500 ASP A 244 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 26 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP B 26 CB - CG - OD2 ANGL. DEV. = -6.9 DEGREES REMARK 500 TYR B 101 CB - CG - CD1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ASP B 111 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 111 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP B 201 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 201 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP B 227 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP B 244 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 13 -147.19 59.73 REMARK 500 CYS A 14 68.69 -101.31 REMARK 500 ASN A 66 164.78 175.37 REMARK 500 LYS B 13 -146.06 53.65 REMARK 500 ALA B 67 163.39 178.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 207 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEETS PRESENTED AS *A* AND *B* ON SHEET RECORDS BELOW REMARK 700 ARE ACTUALLY EIGHT-STRANDED BETA-BARRELS. THESE ARE REMARK 700 REPRESENTED BY NINE-STRANDED SHEETS IN WHICH THE FIRST AND REMARK 700 LAST STRANDS ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PG B 300 DBREF 4TIM A 1 250 UNP P04789 TPIS_TRYBB 1 250 DBREF 4TIM B 1 250 UNP P04789 TPIS_TRYBB 1 250 SEQRES 1 A 250 MET SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SEQRES 2 A 250 CYS ASN GLY SER GLN GLN SER LEU SER GLU LEU ILE ASP SEQRES 3 A 250 LEU PHE ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS SEQRES 4 A 250 VAL VAL ALA SER THR PHE VAL HIS LEU ALA MET THR LYS SEQRES 5 A 250 GLU ARG LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN SEQRES 6 A 250 ASN ALA ILE ALA LYS SER GLY ALA PHE THR GLY GLU VAL SEQRES 7 A 250 SER LEU PRO ILE LEU LYS ASP PHE GLY VAL ASN TRP ILE SEQRES 8 A 250 VAL LEU GLY HIS SER GLU ARG ARG ALA TYR TYR GLY GLU SEQRES 9 A 250 THR ASN GLU ILE VAL ALA ASP LYS VAL ALA ALA ALA VAL SEQRES 10 A 250 ALA SER GLY PHE MET VAL ILE ALA CYS ILE GLY GLU THR SEQRES 11 A 250 LEU GLN GLU ARG GLU SER GLY ARG THR ALA VAL VAL VAL SEQRES 12 A 250 LEU THR GLN ILE ALA ALA ILE ALA LYS LYS LEU LYS LYS SEQRES 13 A 250 ALA ASP TRP ALA LYS VAL VAL ILE ALA TYR GLU PRO VAL SEQRES 14 A 250 TRP ALA ILE GLY THR GLY LYS VAL ALA THR PRO GLN GLN SEQRES 15 A 250 ALA GLN GLU ALA HIS ALA LEU ILE ARG SER TRP VAL SER SEQRES 16 A 250 SER LYS ILE GLY ALA ASP VAL ALA GLY GLU LEU ARG ILE SEQRES 17 A 250 LEU TYR GLY GLY SER VAL ASN GLY LYS ASN ALA ARG THR SEQRES 18 A 250 LEU TYR GLN GLN ARG ASP VAL ASN GLY PHE LEU VAL GLY SEQRES 19 A 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE LYS SEQRES 20 A 250 ALA THR GLN SEQRES 1 B 250 MET SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SEQRES 2 B 250 CYS ASN GLY SER GLN GLN SER LEU SER GLU LEU ILE ASP SEQRES 3 B 250 LEU PHE ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS SEQRES 4 B 250 VAL VAL ALA SER THR PHE VAL HIS LEU ALA MET THR LYS SEQRES 5 B 250 GLU ARG LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN SEQRES 6 B 250 ASN ALA ILE ALA LYS SER GLY ALA PHE THR GLY GLU VAL SEQRES 7 B 250 SER LEU PRO ILE LEU LYS ASP PHE GLY VAL ASN TRP ILE SEQRES 8 B 250 VAL LEU GLY HIS SER GLU ARG ARG ALA TYR TYR GLY GLU SEQRES 9 B 250 THR ASN GLU ILE VAL ALA ASP LYS VAL ALA ALA ALA VAL SEQRES 10 B 250 ALA SER GLY PHE MET VAL ILE ALA CYS ILE GLY GLU THR SEQRES 11 B 250 LEU GLN GLU ARG GLU SER GLY ARG THR ALA VAL VAL VAL SEQRES 12 B 250 LEU THR GLN ILE ALA ALA ILE ALA LYS LYS LEU LYS LYS SEQRES 13 B 250 ALA ASP TRP ALA LYS VAL VAL ILE ALA TYR GLU PRO VAL SEQRES 14 B 250 TRP ALA ILE GLY THR GLY LYS VAL ALA THR PRO GLN GLN SEQRES 15 B 250 ALA GLN GLU ALA HIS ALA LEU ILE ARG SER TRP VAL SER SEQRES 16 B 250 SER LYS ILE GLY ALA ASP VAL ALA GLY GLU LEU ARG ILE SEQRES 17 B 250 LEU TYR GLY GLY SER VAL ASN GLY LYS ASN ALA ARG THR SEQRES 18 B 250 LEU TYR GLN GLN ARG ASP VAL ASN GLY PHE LEU VAL GLY SEQRES 19 B 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE LYS SEQRES 20 B 250 ALA THR GLN HET 2PG B 300 11 HETNAM 2PG 2-PHOSPHOGLYCERIC ACID FORMUL 3 2PG C3 H7 O7 P FORMUL 4 HOH *130(H2 O) HELIX 1 1A GLN A 18 SER A 30 1 13 HELIX 2 2A LEU A 48 ARG A 54 1 7 HELIX 3 3A LEU A 80 ASP A 85 1 6 HELIX 4 4FA SER A 96 TYR A 101 1 6 HELIX 5 4A ASN A 106 ALA A 118 1 13 HELIX 6 5FA LEU A 131 GLU A 135 1 5 HELIX 7 5A THR A 139 LYS A 152 1 14 HELIX 8 6BA LYS A 156 LYS A 161 5 6 HELIX 9 6A PRO A 180 LYS A 197 1 18 HELIX 10 7BA ALA A 200 GLU A 205 1 6 HELIX 11 7A GLY A 216 TYR A 223 1 8 HELIX 12 8FA GLY A 235 LEU A 238 5 4 HELIX 13 8A PHE A 242 LYS A 247 1 6 HELIX 14 1B GLN B 18 ASN B 29 1 12 HELIX 15 2B LEU B 48 ARG B 54 1 7 HELIX 16 3B LEU B 80 ASP B 85 1 6 HELIX 17 4FB SER B 96 TYR B 101 1 6 HELIX 18 4B ASN B 106 ALA B 118 1 13 HELIX 19 5FB LEU B 131 GLU B 135 1 5 HELIX 20 5B THR B 139 ALA B 151 1 13 HELIX 21 6BB LYS B 156 LYS B 161 5 6 HELIX 22 6B PRO B 180 LYS B 197 1 18 HELIX 23 7BB ALA B 200 GLU B 205 1 6 HELIX 24 7B ALA B 219 GLN B 224 1 6 HELIX 25 8FB GLY B 235 LEU B 238 5 4 HELIX 26 8B PHE B 242 LYS B 247 1 6 SHEET 1 A 9 ILE A 7 ASN A 11 0 SHEET 2 A 9 GLN A 38 SER A 43 1 SHEET 3 A 9 PHE A 60 ALA A 64 1 SHEET 4 A 9 TRP A 90 LEU A 93 1 SHEET 5 A 9 MET A 122 ILE A 127 1 SHEET 6 A 9 VAL A 162 TYR A 166 1 SHEET 7 A 9 ARG A 207 TYR A 210 1 SHEET 8 A 9 GLY A 230 VAL A 233 1 SHEET 9 A 9 ILE A 7 ASN A 11 1 SHEET 1 B 9 ILE B 7 ASN B 11 0 SHEET 2 B 9 GLN B 38 ALA B 42 1 SHEET 3 B 9 PHE B 60 ALA B 64 1 SHEET 4 B 9 TRP B 90 LEU B 93 1 SHEET 5 B 9 MET B 122 ILE B 127 1 SHEET 6 B 9 VAL B 162 TYR B 166 1 SHEET 7 B 9 ILE B 208 TYR B 210 1 SHEET 8 B 9 GLY B 230 VAL B 233 1 SHEET 9 B 9 ILE A 7 ASN A 11 1 SITE 1 AC1 16 ASN B 11 LYS B 13 HIS B 95 GLU B 167 SITE 2 AC1 16 ALA B 171 ILE B 172 GLY B 173 GLY B 211 SITE 3 AC1 16 GLY B 212 SER B 213 LEU B 232 GLY B 234 SITE 4 AC1 16 GLY B 235 HOH B 657 HOH B 663 HOH B 698 CRYST1 112.590 97.290 46.700 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008882 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010279 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021413 0.00000